Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
Research
St. Jude Children’s Research Hospital
ALSAC
Danny Thomas, Founder
Finding cures. Saving children.
Who are childhood cancer survivors?
More than 325,000 people in the U.S.
That’s 1 in 680 adults between ages 20-50
Numbers are for long-term survival, defined as 5 or more years from diagnosis
1962: St. Jude first opens its doors. Cancer survival was 20 percent
Today: Cancer survival is 80 percent
Our goal: 100 percent
Leukemia: 34 percent
Brain and nervous system malignancies: 27 percent
Neuroblastoma: 7 percent
Wilms tumor: 5 percent
Hodgkin lymphoma: 4 percent
Non-Hodgkin lymphoma: 4 percent
Retinoblastoma: 3 percent
Rhabdomyosarcoma: 3 percent
Osteosarcoma: 3 percent
Ewing sarcoma: 1 percent
Other: 9 percent
98 percent: The percent of all St. Jude cancer patients that have participated in a clinical research study
First: St. Jude is the 1st and only NCI-designated Comprehensive Cancer Center focused solely on children.
Long-term survival, defined as 5 or more years from diagnosis
Number of long-term survivors being monitored at St. Jude: over 6,500
The unique St. Jude LIFE study brings back long-term survivors for clinical follow-up throughout their adult lives. Current enrollment: over 2,400
St. Jude leads the Childhood Cancer Survivor Study (CCSS), the largest single source of self-reported survivorship data in the world. Current enrollment: over 22,000
Howlader, N. et al., SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations)
Mariotto, A.B. et al., Cancer Epidemiol Biomarkers Prev., 2009 Apr;18(4):1033-40.
Siegel, R. et al., CA Cancer J Clin., 2012 Jul-Aug;62(4):220-41.
St. Jude Children’s Research Hospital
